Serentis
23 Cambridge Science Park
Milton Road
Cambridge
CB4 0EY
United Kingdom
Tel: 01223-437064
Fax: 01223-437063
Website: http://www.serentis-pharma.com/
Email: info@serentis-pharma.com
6 articles about Serentis
-
Serentis Starts Phase II Trial with First-in-Class SRD441 for Eczema
4/7/2009
-
Serentis Starts Phase II Clinical Trial in Pruritus of Skin Disease
3/4/2009
-
Serentis Expands Series A Financing
8/12/2008
-
Serentis Appoints Peter Keen as New Corporate Development and Finance Director
10/30/2007
-
Serentis Acquires Atopic Dermatitis Company Surface Therapeutics
10/2/2007
-
Serentis Raises £10.3 Million Series A Financing
7/3/2007